REFERENCES
- Greenberg G, Rosenheck R. National Mental Health Program Performance Monitoring System: Fiscal Year 2002 Report. Northeast Program Evaluation Center, Veterans Affairs; 2003.
- Rieger DA, Farmer ME, Rae DS. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA. 1990;264:2511–2518. [CSA]
- Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35:S93–S100. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gerding LB, Labbate LA, Measom MO, , et al. Alcohol dependence and hospitalization in schizophrenia. Schizophr Res. 1999;38:71–75. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ziedonis D, Richardson T, Lee E, , et al. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics. Psychopharmacol Bull. 1992;28:309–314. [PUBMED], [INFOTRIEVE], [CSA]
- Petrakis IL, O'Malley S, Rounsaville B, , et al. Naltrexone augmentation of neuroleptic "treatment in alcohol abusing patients with schizophrenia. Psychopharmacology. 2004;172:291–297. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kane J, Honigfeld G, Singer J, , et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789–796. [PUBMED], [INFOTRIEVE], [CSA]
- Tollefson GD, Beasley CM Jr, Tran PV, , et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry. 1997;154:457–465. [PUBMED], [INFOTRIEVE], [CSA]
- Small JG, Hirsch SR, Arvanitis LA, , et al. Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo, Seroquel study group. Arch Gen Psychiatry. 1997;54:549–557. [PUBMED], [INFOTRIEVE], [CSA]
- Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994;151:825–835. [PUBMED], [INFOTRIEVE], [CSA]
- Markowitz JS, Brown CS, Moore TR. Atypical antipsychotics, part I: pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother. 1999;33:73–85. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259–1264. [PUBMED], [INFOTRIEVE], [CSA]
- Krystal JH, D'Souza DC, Madonic S, , et al. Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophr Res. 1999;35(Suppl):S35–S49. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wilkins J. Pharmacotherapy of schizophrenia patients with comorbid substance abuse. Schizophr Bull. 1997;23:215–228. [PUBMED], [INFOTRIEVE], [CSA]
- Buckley PF. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. J Subst Abuse Treat. 1998;15:113–116. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Albanese MJ, Khantzian EJ, Murphy SL, , et al. Decreased substance use in chronically psychotic patients treated with clozapine [letter]. Am J Psychiatry. 1994;151:780–781. [PUBMED], [INFOTRIEVE], [CSA]
- Yovell Y, Opler LA. Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis. J Nerv Ment Dis. 1994;182:591–592. [PUBMED], [INFOTRIEVE], [CSA]
- Marcus P, Snyder R. Reduction of comorbid substance abuse with clozapine. Am J Psychiatry. 1995;152:959. [PUBMED], [INFOTRIEVE], [CSA]
- Volavka J. The effects of clozapine on aggression and substance abuse in schizophrenic patients. J Clin Psychiatry. 1999;60:43–46. [PUBMED], [INFOTRIEVE], [CSA]
- Kosten TA, Nestler EJ. Clozapine attenuates cocaine-conditioned place preference. Life Sci. 1994;55:L9–L14. [CSA], [CROSSREF]
- Drake RE, Xie H, McHugo GJ, , et al. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull. 2000;26:441–449. [PUBMED], [INFOTRIEVE], [CSA]
- Littrell K, Petty R, Hilligoss N, Peabody C, Johnson C. Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat. 2001;21:217–221. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McLellan A, Luborsky L, Woody G, , et al. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26–33. [PUBMED], [INFOTRIEVE], [CSA]
- Carroll KM, Nich C, Ball SA, , et al. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93:713–727. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Anton RF, Moak DH, Waid R, , et al. Naltrexone and cognitive behavioral therapy for treatment of outpatient alcoholics: result, a placebo-controlled trial. Am J Psychiatry. 1999;156:1758–1764. [PUBMED], [INFOTRIEVE], [CSA]
- Project Match Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7–29. [CSA]
- Crits-Christoph P, Siqueland L, Blaine JD, , et al. Psychosocial treatments for cocaine "dependence. Arch Gen Psychiatry. 1999;56:493–502. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rosenheck R, Perlick D, Bingham SF, , et al. Effectiveness and cost of olanzapine and "haloperidol in the treatment of schizophrenia: a randomized and controlled trial. JAMA. 2003;290:2693–2702. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kampman KM, Pettinati H, Lynch KG, , et al. A pilot trial of olanzapine for the treatment of cocaine dependence. Drug Alcohol Depend. 2003;70:265–273. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Volpicelli JR, Alterman A, Hayashida M, , et al. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876–880. [PUBMED], [INFOTRIEVE], [CSA]
- O'Malley SS, Jaffe AJ, Chang G, , et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:881–887. [PUBMED], [INFOTRIEVE], [CSA]
- Carroll KM. Manual-guided psychosocial treatment: a new virtual requirement for pharmacotherapy trials? [comment]. Arch Gen Psychiatry. 1997;54:923–928. [PUBMED], [INFOTRIEVE], [CSA]
- Mueser K, Noordsy D, Fox L, , et al. Disulfiram treatment for alcoholism in severe mental illness. Am J Addict. 2003;12:242–252. [PUBMED], [INFOTRIEVE], [CSA]
- Shaner A, Roberts LJ, Eckman TA, , et al. Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr Serv. 1997;48:807–810. [PUBMED], [INFOTRIEVE], [CSA]